๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The M5 muscarinic receptor as possible target for treatment of drug abuse

โœ Scribed by R. B. Raffa

Book ID
108849265
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
211 KB
Volume
34
Category
Article
ISSN
0269-4727

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The relative selectivity of anticholiner
The relative selectivity of anticholinergic drugs for the M1 and M2 muscarinic receptor subtypes
โœ Dr. Robert E. Burke ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 775 KB

Anticholinergic drugs are used to treat a number of neurologic disorders, inctuding parkinsonism, vestibular disturbances, and dystonia. Traditionally, these drugs have been thought to act in similar fashion, as competitive antagonists at a single class of muscarink receptors, and not to differ sign

Neuronal nicotinic acetylcholine recepto
Neuronal nicotinic acetylcholine receptors as a target for the treatment of neuropathic pain
โœ Michael D. Meyer ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 102 KB ๐Ÿ‘ 1 views

## Abstract Neuronal nicotinic acetylcholine receptor (nAChR) agonists have been demonstrated to exhibit antinociceptive, antihyperalgesic, and antiallodynic effects across a range of preclinical models of pain. Yet, to date, no drugs have been successfully developed and approved for the treatment